Rubric Capital Management (New York)’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Sell |
478,533
-4,837,436
| -91% | -$1.6M | ﹤0.01% | 63 |
|
|
2025
Q1 | $1.66M | Hold |
5,315,969
| – | – | 0.03% | 63 |
|
|
2024
Q4 | $4.96M | Hold |
5,315,969
| – | – | 0.06% | 62 |
|
|
2024
Q3 | $6.27M | Hold |
5,315,969
| – | – | 0.1% | 55 |
|
|
2024
Q2 | $4.09M | Hold |
5,315,969
| – | – | 0.11% | 62 |
|
|
2024
Q1 | $16.2M | Hold |
5,315,969
| – | – | 0.48% | 50 |
|
|
2023
Q4 | $17.1M | Sell |
5,315,969
-129,941
| -2% | -$418K | 0.36% | 40 |
|
|
2023
Q3 | $20.9M | Hold |
5,445,910
| – | – | 0.78% | 32 |
|
|
2023
Q2 | $17.9M | Sell |
5,445,910
-1,555,214
| -22% | -$5.1M | 0.76% | 38 |
|
|
2023
Q1 | $18.1M | Buy |
7,001,124
+173,059
| +3% | +$446K | 0.47% | 44 |
|
|
2022
Q4 | $12.7M | Buy |
6,828,065
+2,311,765
| +51% | +$4.3M | 0.55% | 49 |
|
|
2022
Q3 | $8.31M | Buy |
4,516,300
+1,633,594
| +57% | +$3.01M | 0.42% | 52 |
|
|
2022
Q2 | $6.2M | Buy |
+2,882,706
| New | +$6.2M | 0.33% | 55 |
|